博文
【专刊征稿】TMSR┃Covid-19代谢后果和诱发因素
|
Covid-19不仅潜移默化地改变了人们正常行为模式和生活方式。对易感人群的影响更是不可忽视。有研究显示肥胖和代谢综合症患者更容易感染严重的急性呼吸综合征冠状病毒II（SARS-CoV-2或Covid-19），与此同时，也有人提出 Covid-19可改能会改变新发糖尿病的发展轨迹。
了解Covid-19与代谢综合症之间关联的原因会为我们如何更好地管理易感人群以预防严重疾病提供更多思路。
本期专刊征稿特围绕这一主题展开，欢迎大家积极投稿。
主题范围
包括但不限于
Covid-19 对新发糖尿病的影响
The impact of Covid-19 on new onset diabetes
Covid-19 对与代谢综合症相关的生化和人体测量因素的影响
The effects of Covid-19 on biochemical and anthropometric factors associated with metabolic syndrome
增加Covid-19感染易感性相关的代谢综合症体征
Features of metabolic syndrome associated with an increased susceptibility to Covid-19 infection
对 Covid-19 感染及其并发症的易感性增加的诱因机制
Mechanisms leading to increased susceptibility to Covid-19 infection and its complications
Covid-19 感染如何影响行为模式和生活方式，包括饮食和身体活动
How Covid-19 infection affects behavioural and lifestyle factors, including diet and physical activity
客座编辑
Professor Ferns
Brighton & Sussex Medical School, UK
Professor Ghayour
Mashhad Uniuversity Medical School, Iran
Professor Alkhatib
Dasman Diabetes Institute, Kuwait
Dr Rovce Vincent
King's College Hospital, Denmark Hill, UK
投稿须知
投稿前请仔细阅读期刊主页的“Guide for Authors”
投稿链接：
投稿时请选择 “Covid-19: its metabolic consequences and predisposing factors”
Guide for Authors页面
投稿页面
截稿日期：2022年10月31日
期刊介绍
About the Journal
期刊主页
Translational Metabolic Syndrome Research（《转化代谢综合症研究》）是全球华人医学科学家学者协会 & 中国研究型医院学会官方期刊，期刊致力于发表来自新陈代谢转化研究领域的研究成果，刊载文章主要范围包括新陈代谢综合症的预防，治疗，管理和诊断，文章类型包括但不局限于研究论文，综述，简报论文，假说等。
所有文章将经过严格的同行评审，一经录用将发表在月活用户超过1700万的ScienceDirect平台，供领域内的学者及全球读者免费阅读、下载及引用。
主编介绍
Editor in Chief
Wei Wang
MD, PhD, FFPH, FRSB, FRSM
Professor, Edith Cowan University, Australia
Biography
Professor Wei Wang has published over 200 scientific papers in prestigious journals, including Science, Nature Genetics and The Lancet. He was the founding Chief Editor of the Journal of Family Medicine and Community Health.
Currently he is
Chief Editor of Translational Metabolic Syndrome Research
Associate Editor of EPMA Journal
Regional Editor of Journal of Global Health and Journal of Human Hypertension
Editor (Engineering) and Guest Editor for Frontiers in Immunology
He has been elected a Fellow of the following organisations:
Faculty of Public Health, Royal College of Physicians (2005)
Royal Society of Biology (2016)
Royal Society of Medicine of the United Kingdom (2017)
Professor Gordon Ferns
Brighton and Sussex Medical School, UK
Biography
Professor Gordon Fernsqualified in medicine from St Bartholomew’s Medical College, University of London. Following House jobs in Newmarket and London, he trained in Chemical Pathology at St Bartholomew’s Hospital, London, where he also undertook the research for his MD, funded by a Wellcome Pathology Research Fellowship and Aylwen Research Bursary.
He was a British Heart Foundation-American Heart Association Reciprocal Fellow in the Department of Pathology at the University of Washington, Seattle, US, returning to the UK as a Senior Scientist at the William Harvey Research Institute, London.
He was appointed Senior Lecturer in Chemical Pathology at the University of Leicester, and then to a Chair in Metabolic & Molecular Medicine at the University of Surrey. He was subsequently Dean of Medicine at the University of Surrey, before his move to the University of Keele Medical School, where he was Director of the Institute of Science and Technology in Medicine. Gordon has worked at BSMS since 2012 as Head of the Department of Medical Education, and Honorary Consultant in Metabolic Medicine.
https://blog.sciencenet.cn/blog-3496796-1351286.html
上一篇：KeAi Talks┃Fundamental Research系列研讨会首场亮相！
下一篇：【专刊征稿】ENCECO┃矿山污染物对环境的生态毒性及其修复
